Title The long-term survival of esophageal cancer in elderly patients: A multi-center, retrospective study from China
Authors Li, Runhua
He, Yutong
Sun, Xibin
Wang, Ning
Zhang, Min
Wei, Kuangrong
Li, Huizhang
Dong, Peng
Du, Lingbin
Chen, Wanqing
Affiliation Chinese Acad Sci, Univ Chinese Acad Sci, Zhejiang Canc Hosp,Zhejiang Key Lab Diag & Treatm, Canc Hosp,Inst Basic Med & Canc IBMC,Dept Canc Pr, Hangzhou 310022, Zhejiang, Peoples R China
Hebei Med Univ, Hosp 4, Tumor Hosp Hebei Prov, Canc Inst, Shijiazhuang, Hebei, Peoples R China
Henan Canc Hosp, Zhengzhou, Henan, Peoples R China
Peking Univ, Beijing Canc Hosp, Canc Hosp, Beijing, Peoples R China
Hubei Canc Hosp, Wuhan, Peoples R China
Zhongshan City Peoples Hosp, Canc Inst, Zhongshan, Guangdong, Peoples R China
Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing 100021, Peoples R China
Keywords SQUAMOUS-CELL CARCINOMA
RISK
EPIDEMIOLOGY
MANAGEMENT
DIET
ASSOCIATION
STATISTICS
DRINKING
WESTERN
HABITS
Issue Date Oct-2022
Publisher CANCER MEDICINE
Abstract Background Esophageal cancer (EC) often occurs in the elderly, and approximately 40% of patients are 70 years or older. To investigate the long-term survival of EC in elderly patients, to provide a theoretical direction for better management and predicting survival of EC based on the hospital-based multi-center study in China. Methods The study was conducted in 18 hospitals including 6 provincial hospitals, 8 municipal hospitals, and 4 county hospitals. We extracted information from medical record homepage, records of admission and discharge, and pathological diagnosis reports from the medical record department of the elderly patients at 70-84 years old to obtain the 3-year and 5-year overall survival (OS), and main associated factors, and to analyze the current therapeutic effect of different treatment options for elderly patients. Results The 3-year and 5-year OS rate of the 1013 elderly patients was 44.8% and 32.8%, respectively. Their median survival was 28.00 months. The median survival of patients with squamous cell carcinoma was longer than that of other pathological type (squamous vs. other types: 31.00 vs. 20.00 months, p = 0.018). The median survival of patients with surgery only or combined therapy was longer than that of radiotherapy, chemotherapy, and no therapy (surgery only vs. combined therapy vs. radiotherapy vs. chemotherapy vs. no therapy: 56.00 vs. 33.00 vs. 26.00 vs.18.00 vs. 16.00 months, p < 0.001). The 5-year OS rate of patients with highly differentiated cancer was higher than that of medium differentiated and poor differentiation/undifferentiated. In multivariate analysis, the older ages, pathological stage, were independent prognostic risk factors for poor EC survival. Treatment method was independent protective factors predictive of a good EC OS. Conclusions The survival rate of the elderly EC patients was still low in China. Age, therapy method, and pathological stage were mainly associated with the survival rate of EC in elderly patients.
URI http://hdl.handle.net/20.500.11897/655705
ISSN 2045-7634
DOI 10.1002/cam4.5307
Indexed SCI(E)
Appears in Collections: 北京肿瘤医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.